Introduction
============

Anemia, according to the World Health Organization (WHO) criteria, is defined as a hemoglobin concentration \<13.0 g/dL (8.0 mmol/L) in adult men and \<12.0 g/dL (7.5 mmol/L) in adult, non-pregnant women. Anemia affects nearly 25% of the world population.^[@b1-1040468],[@b2-1040468]^ In developed countries, anemia is one of the most frequent conditions in older individuals, with a presumed prevalence of over 10% individuals who are 65 years or older in selected populations.^[@b3-1040468],[@b4-1040468]^ More than half of anemic older individuals can be diagnosed with nutritional deficiencies or have anemia of chronic inflammation (ACI). The etiology of anemia remains unknown in about one-third of the older population.^[@b4-1040468]^ In older individuals the presence of anemia, even mild anemia, is associated with an increased risk of falls,^[@b5-1040468]^ decreased physical performance,^[@b6-1040468]^ longer and more frequent stays in hospital,^[@b7-1040468]--[@b9-1040468]^ and increased mortality.^[@b7-1040468],[@b9-1040468],[@b10-1040468]^ Suggestions to raise the hemoglobin thresholds for the definition of anemia in older individuals have been made in several studies.^[@b11-1040468],[@b12-1040468]^

The impact of anemia on health-related quality of life (HRQoL) has been studied in different populations of patients, including patients with chronic kidney disease,^[@b13-1040468]^ chronic obstructive pulmonary disease,^[@b14-1040468]^ cancer^[@b15-1040468]^ and heart failure.^[@b16-1040468]^ In these studies, anemia was reported to be associated with a reduced HRQoL. However, little research has been done on this potential association in community-dwelling populations. Better understanding of the impact of anemia on HRQoL in a community-dwelling general population is therefore essential and could provide critical entry points for interventions that affect anemia, especially in older individuals.

In this study, we investigated the association between anemia and survival, and between anemia and HRQoL. In addition, we used this association to evaluate the definition of anemia, considering the impact of age and gender on this association in the large community-dwelling population from the Lifelines cohort.^[@b17-1040468]^

Methods
=======

Subjects
--------

In this study we used data from 138670 subjects participating in the Lifelines cohort study. Data from quality of life questionnaires and on hemoglobin concentration were available for these subjects. Lifelines is a multidisciplinary, prospective, population-based cohort study examining, in a unique three-generation design, the health and health-related behaviors of persons living in the north of the Netherlands. It has been shown that the Lifelines cohort is representative of the population of the northern part of the Netherlands.^[@b18-1040468]^ The local ethics committee approved the research protocol and informed consent was signed by every participant.

Health-related quality of life
------------------------------

HRQoL was measured using the RAND 36-Item Health Survey.^[@b19-1040468]^ Since HRQoL scores are not normally distributed, for each subscale we defined a sex-specific and age-specific cut-off point at the 25^th^ percentile of the non-anemic Lifelines population. Participants with a score lower than 25^th^ percentile were considered to have an abnormally low score for that specific subscale.

Survival
--------

All participants were followed from the moment of their inclusion in the Lifelines cohort until death or up to May 2018 (maximum follow-up 138 months, median 79 months). Information on participants' deaths was obtained from the municipal personal records database.

Definition of anemia and classification into subtypes of anemia
---------------------------------------------------------------

In accordance with the WHO criteria, anemia was defined as a hemoglobin concentration \<13.0 g/dL (8.0 mmol/L) in adult men and \<12.0 g/dL (7.5 mmol/L) in adult, non-pregnant women.^[@b20-1040468]^ In anemic subjects older than 60 years of age additional biochemical tests were performed, using stored plasma, to determine the type of anemia: anemia due to nutritional deficiency, ACI or unexplained anemia. There is no worldwide accepted classification into subtypes of anemia. Reference values were taken from the University Medical Center Groningen or from published literature, as indicated. Iron deficiency was considered present if the participant had two or three of the following criteria: serum ferritin concentration \<30 μg/L, transferrin saturation rate \<16% or hepcidin concentration \<0.5 nmol/L.^[@b21-1040468]--[@b23-1040468]^ Transferrin saturation was calculated by dividing serum iron by total iron-binding capacity \[transferrin (g/L)×25\]. Folate deficiency was defined as a serum folate level \<9.8 nmol/L. Vitamin B12 deficiency was defined as a serum methylmalonic acid concentration \>340 nmol/L, if the estimated glomerular filtration was \>30 mL/min (because methylmalonic acid levels may be elevated in people with severely impaired renal function^[@b24-1040468]^). If there was no evidence of nutrient deficiency, subjects with anemia were evaluated for other causes. Subjects were classified as having anemia related to chronic renal disease if the estimated glomerular filtration rate was \<30 mL/min. The Chronic Kidney Disease-Epidemiology Collaboration (CDK-EPI) formula was used to calculate the estimated glomerular filtration rate. ACI was defined as present if the participant had (i) a C-reactive protein concentration \>5.0 mg/L or an absolute number of leukocytes \>10×10^9^/L and (ii) two or more of the following criteria: transferrin saturation rate \<16%, serum ferritin concentration \>100 μg/L, serum iron \<10 μmol/L and hepcidin \>14.7 nmol/L in men or hepcidin\>15.6 nmol/L in women.^[@b25-1040468],[@b26-1040468]^ If subjects with anemia could not be classified into any of these categories, they were considered, by exclusion, to have unexplained anemia.

Details of the Lifelines cohort, clinical examination, biochemical measurements, RAND 36-Item Health Survey and data description and statistical analysis are provided in the *Online Supplementary Data*.

Results
=======

Relevant baseline characteristics are shown in [Table 1](#t1-1040468){ref-type="table"} for anemic and non-anemic participants from the population-based Lifelines cohort. In total 551 men and 4959 women met the WHO criteria for anemia. The overall prevalence of anemia was 4.0% ([Figure 1A](#f1-1040468){ref-type="fig"}). The prevalence of anemia in women was highest (about 8%) in the age cohort 40-49 years and showed a second peak of about 4% at an older age (older than 70 years). In contrast, the prevalence of anemia in men gradually increased with age, with a peak of about 5% in older age (older than 70 years). In the population of individuals 60 years of age and older the overall prevalence of anemia was 2.8%, with a prevalence of 2.7% in men and 3.0% in women. The distribution of the hemoglobin concentration according to age is shown in *Online Supplementary Figure S2A,C*. In men, unlike in women, the mean hemoglobin concentration decreased with age (*Online Supplementary Figure S2B,D*). Over 90% of the anemic individuals had mild anemia \[\>10 g/dL, (\> 6.2 mmol/L)\]. In individuals younger than 60 years the presence of anemia did not have any impact on overall survival ([Figure 1B](#f1-1040468){ref-type="fig"}). In contrast, the overall survival of anemic individuals older than 60 years was significantly lower than that of non-anemic individuals older than 60 years ([Figures 1C](#f1-1040468){ref-type="fig"}).

###### 

Baseline characteristics of the study cohort.

![](104468.tab1)

![Prevalence of anemia and overall survival in individuals younger and older than 60 years. (A) The prevalence of anemia as a function of sex and age. (B) Overall survival of non-anemic and anemic individuals younger than 60 years. (C) Overall survival of non-anemic and anemic individuals older than 60 years.](104468.fig1){#f1-1040468}

The mean of the total HRQoL score was significantly lower in anemic individuals in all age groups than in non-anemic individuals (*Online Supplementary Figure S3A*). At a younger age the mean difference was relatively small, but after the age of 60 years this difference in mean HRQoL increased substantially. Because HRQoL scores are not normally distributed, we also studied the percentage of individuals with a HRQoL score below a cutoff value. This analysis revealed that the percentage of individuals with a total score below the 25^th^ percentile was significantly higher among the group of individuals over 60 years old (*Online Supplementary Figure S3B*). Older individuals had a significantly lower mean HRQoL in the subscales physical functioning, social functioning, physical role functioning, emotional role functioning, vitality, bodily pain and general health (*Online Supplementary Figure S4*). Moreover, a significantly larger proportion of anemic subjects older than 70 years had a score below the cut-off value, indicating a poor score, in six of the eight subscales: physical functioning (40% *versus* 25%), social functioning (42% *versus* 33%), physical role functioning (35% *versus* 23%), vitality (36% *versus* 27%), bodily pain (45% *versus* 32%) and general health (42% *versus* 32%). In subjects between 60-70 years old there was a difference in the subscales physical functioning (36% *versus* 27%) and physical role functioning (29% *versus* 21%) ([Figure 2](#f2-1040468){ref-type="fig"}). Between 18-60 years no significant differences were observed when comparing percentages of individuals with a HRQoL score below the cut-off value. Finally, we used multivariate logistic regression analysis to investigate whether anemia was an independent risk factor for HRQoL. This analysis showed that anemia, adjusted for body mass index, being a current smoker, multiple drug use, educational level and living situation independently increased the risk of having a lower total HRQoL (OR 1.28; 95% CI: 1.00 -- 1.64; *P*=0.046).

![Percentages of individuals, divided according to age group, with scores below the sex- and age-specific cut-off values for the different subscales of the RAND-36 health survey. An asterisk indicates a significantly (*P*-value \<0.01) larger percentage below the sex- and age-specific cut-off value in anemic individuals compared with non-anemic individuals. PF: physical functioning; SF: social functioning; RF: physical role functioning; RE: emotional role functioning; MH: mental health; VT: vitality; BP: bodily pain; GH: general health.](104468.fig2){#f2-1040468}

Since anemia had a particular impact on overall survival and HRQoL in subjects older than 60 years within the Lifelines cohort, the type of anemia in these individuals was further characterized (see the Methods section). In total 174 (35.0%) subjects were classified as having nutrient deficiency anemia, 81 (16.3%) as having ACI, and 242 (48.7%) as having unexplained anemia (*Online Supplementary Table S1*). Compared with individuals from the general population, a significantly larger proportion of individuals with ACI had a HRQoL score lower than the cut-off value in seven of the eight subscales (all except mental health) ([Table 2](#t2-1040468){ref-type="table"}). Nutrient deficiency anemia was associated with a significantly lower score in only one subscale (physical functioning). Individuals with unexplained anemia had a significantly lower score in the subscale bodily pain. These results were more explicit in men than in women (*Online Supplementary Tables S2* and *S3*). In order to determine which type of anemia was an independent risk factor for HRQoL in individuals older than 60 years, we performed logistic regression analysis in individuals older than 60 years ([Table 3](#t3-1040468){ref-type="table"} and *Online Supplementary Table S4*). After adjusting for body mass index, being a current smoking, multiple drug use, educational level and living situation, ACI was associated with a higher risk of having a score below the cut-off in all seven subscales which were affected by anemia (i.e. all subscales except mental health) ([Table 3](#t3-1040468){ref-type="table"}). Overall survival was significantly lower in individuals with ACI than in those with nutrient deficiency anemia or unexplained anemia ([Figure 3](#f3-1040468){ref-type="fig"}).

###### 

Percentage of individuals older than 60 years with anemia with HRQoL below the sex- and age-specific cut-off value for the different HRQoL subscales as a function of their type of anemia.

![](104468.tab2)

###### 

Risk of having a lower score than the (age- and sex- specific) 25^th^ percentile cut-off due to anemia per HRQoL subscale among individuals older than 60 years.

![](104468.tab3)

![Kaplan-Meier curves of survival of individuals with different types of anemia.](104468.fig3){#f3-1040468}

Although the difference between the median values of the hemoglobin concentration decreased during aging, (*Online Supplementary Figure S5*), the definition of anemia is based on hemoglobin concentrations obtained in younger adults. Consequently, there are persistent discussions regarding whether the definition of anemia in older individuals is appropriate or should be corrected using a higher hemoglobin threshold. Because of the clear correlation between anemia in individuals older than 60 years and survival and HRQoL, we used these associations to reassess the definition of anemia in individuals older than 60 years. We assumed that anemia should be considered in the case that a certain hemoglobin level was associated with a significant (negative) impact on HRQoL. Logistic regression was used to model the relationship between hemoglobin concentration and total HRQoL in both men and women. These analyses revealed that men older than 60 years with a hemoglobin concentration between 13.0-13.7 g/dL (8.0-8.5 mmol/L) (just above the current WHO defined threshold) did not have a lower HRQoL compared with men with a hemoglobin concentration \>13.7 g/dL (8.5 mmol/L), suggesting that the current threshold which defines anemia in men is appropriate. However, when specifically comparing women older than 60 years with a hemoglobin concentration between 12.0-13.0 g/dL (7.5-8.0 mmol/L) (considered anemic for men but not anemic for women according to the current WHO definition), this group had a lower HRQoL than that of women with a hemoglobin concentration \>13.0 g/dL (8.0 mmol/L). These data strongly suggest that the optimal definition of anemia for women older than 60 years should be a hemoglobin concentration \<13.0 g/dL (8.0 mmol/L) ([Figure 4](#f4-1040468){ref-type="fig"}). So, in the case that HRQoL is used to define anemia, there would be no difference in the definition between older men and women. Due to the limited number of deaths among groups of individuals divided according to the various intervals of hemoglobin concentration, survival could not be used to model the optimal definition of anemia.

![Risk of having a lower total health-related quality of life score than the (sex- and age-specific) 25^th^ percentile cut-off according to hemoglobin concentrations. The red rectangles indicate a hemoglobin concentration below the currently used World Health Organization definition of anemia. 95% CI: 95% confidence interval.](104468.fig4){#f4-1040468}

Discussion
==========

In this study we observed that anemia is associated with worse overall survival and is an independent risk factor for HRQoL in individuals older than 60 years, in contrast to younger individuals. Although consensus on the subclassification of anemia is lacking, our data suggest that particularly ACI was an independent risk factor for HRQoL in subscales representing physical functioning. Furthermore, we observed that women (but not men) older than 60 years with a hemoglobin concentration in the lower normal WHO range experienced decreased HRQoL. This suggests that the definition of anemia in women older than 60 years should be altered to a hemoglobin concentration \<13.0 g/dL (8.0 mmol/L), which is comparable to the definition of anemia in men.

The prevalence of anemia according to the WHO criteria was 4.0% in the whole cohort and 2.8% among subjects older than 60 years, which is consistent with the findings of population-based studies from Sweden (3.8% in patients 44-73 years old)^[@b27-1040468]^ and Germany (3.2% in subjects 45-75 years old^[@b28-1040468]^ and 6.9% in subjects over 65 years old^[@b29-1040468]^). However, the prevalence of anemia in older individuals in our community-dwelling population was remarkably lower than that found in previous studies.^[@b3-1040468],[@b4-1040468],[@b30-1040468]^ A possible explanation for this discrepancy could be a participation bias in the Lifelines cohort, although earlier observations showed that the Lifelines study population is representative of the general population, with a low risk of selection.^[@b18-1040468]^ The relatively low prevalence of anemia in older individuals could also be related to the high quality and accessibility of the general health system nowadays, especially for older individuals. Furthermore, the prevalence of anemia and the types of anemia might differ according to race and geographical area.^[@b2-1040468],[@b4-1040468]^

Anemia did not have an impact on survival in individuals younger than 60 years. In contrast, among individuals older than 60 years, anemic subjects had a significantly decreased survival. The decreased survival in older anemic individuals is in accordance with that in multiple previous studies.^[@b7-1040468],[@b9-1040468],[@b10-1040468]^ In our study there was increased mortality in older individuals with ACI: this finding is partly in line with the findings of a study by Willems *et al*. who reported increased mortality in subjects with nutrient deficiency anemia and ACI, but not in those with unexplained anemia.^[@b31-1040468]^

Since an aging population results in an increased prevalence of anemia, an understanding of the association between anemia and HRQoL is important. Remarkably, only a few, relatively small studies of community-dwelling populations have described this association. In a study of 717 subjects, Lucca *et al*. showed, after adjustment for a large number of demographic and clinical con-founders, that anemia in elderly Italians (65 - 84 years old) was significantly associated with lower disease-specific QoL, measured with the Functional Assessment of Cancer Therapy-Anemia.^[@b32-1040468]^ Thein *et al*. studied an American cohort of 328 individuals and showed that anemia in subjects older than 65 years was independently associated with impairments in multiple subscales of HRQoL (measured with the Short Form-36), especially in measures of functional limitation.^[@b33-1040468]^ Bang *et al*. also found that anemia was associated with physical impairment in 695 Korean individuals older than 65 years.^[@b34-1040468]^ Our data, in an unprecedented large cohort, confirms the relationship between anemia and HRQoL in older individuals (but not in younger individuals).

There is no worldwide accepted classification into subtypes of anemia. To be able to study the subtypes, we based our criteria on literature or reference values from the local laboratory. In addition to those criteria, we also analyzed the data with different classification criteria (see *Online Supplementary Data* for definitions). Although misclassification within the various subtypes of anemia cannot be excluded, our data suggest that the impact of anemia on HRQoL is mainly present in individuals with ACI (*Online Supplementary Tables S5* and *S6*). The pathophysiology of ACI is multifactorial, including increased levels of inflammatory cytokines that lead to altered iron metabolism, with a key role for the iron regulatory peptide hormone hepcidin.^[@b35-1040468],[@b36-1040468]^ Indeed, elevated levels of inflammatory markers, which are found in older anemic individuals, have been shown to be associated with physical disability.^[@b37-1040468],[@b38-1040468]^ Our observation that anemia mainly affects HRQoL of subjects with ACI is supported by studies showing that erythropoiesis-stimulating agents have an impact on the HRQoL of patients with cancer, HIV/AIDS and chronic kidney disease.^[@b39-1040468]^ In older individuals a positive effect of erythropoiesis-stimulating agents on QoL has been shown in patients with chronic kidney disease,^[@b40-1040468]^ and chemotherapy-induced anemia.^[@b41-1040468]^ In one randomized, blinded, placebo-controlled trial in predominantly African-American elderly women with ACI or unexplained anemia an increase of the hemoglobin concentration by 2 g/dL led to improvements in QoL as measured by the Functional Assessment of Chronic Illness Therapy instrument.^[@b42-1040468]^

The most pronounced association between HRQoL and anemia was observed in older individuals and in subscales related to physical health. This suggests that younger individuals can compensate better for the physical consequences of anemia, limiting the impact of anemia on their HRQoL. For older individuals these compensatory mechanisms might be limited compared to those in younger persons. The ability to engage in physical activities is known to be important for maintaining QoL in older persons.^[@b43-1040468],[@b44-1040468]^

In this study we defined anemia according to the WHO criteria, which define anemia as a hemoglobin concentration \<13.0 g/dL (8.0 mmol/L) in adult men and \<12.0 g/dL (7.5 mmol/L) in adult, non-pregnant women. This is the most commonly used definition of anemia, but the use of this definition in older/elderly populations has been criticized.^[@b11-1040468],[@b12-1040468]^ The WHO criteria were derived from a small study population of healthy, young participants nearly 50 years ago.^[@b20-1040468]^ Based on data from two large American databases, Beutler *et al*. proposed new, slightly higher cut-offs for white women older than 50 years and white men older than 60 years.^[@b12-1040468]^

Although the different distributions of median hemoglobin concentration between men and women (in general and in older individuals) suggest that it is 'logic' to use different definitions of anemia in men and women, our data raise doubts about this logic. Indeed, HRQoL data from our study suggest that the definition of anemia in men -- a hemoglobin concentration \<13.0 g/dL (8.0 mmol/L) -- should also be applied for women older than 60 years. Apparently, the hemoglobin values which start to hamper (physical) functioning do not differ between older men and women. We were not able to study the optimal definition of anemia in perspective of mortality because of the limited number of deaths in our cohort. Martinsson *et al*. observed an increased mortality defining anemia as \<14.0 g/dL (8.7 mmol/L) in men and \<13.0 g/dL (8.0 mmol/L) in women.^[@b27-1040468]^ A recent, large study assessing the effect of hemoglobin concentrations on cardiovascular and all-cause mortality in nearly 300,000 participants showed that men with a hemoglobin concentration in the lower normal range had a higher risk of mortality whereas this was not observed in women.^[@b45-1040468]^

Our study has some strengths and limitations. It is the first study to investigate the possible effect of anemia on HRQoL in individuals of all ages in a very large cohort from the general population. Additionally, we used information on HRQoL from a large number of participants with a wide range of age, socio-economic status and co-morbidities. All subjects were uniformly characterized and were not aware of hemoglobin status when filling out the questionnaires, preventing the outcome of the questionnaire from being affected by the knowledge of a diagnosis of anemia.

Several potential limitations should be acknowledged. As mentioned earlier, the subtypes of anemia might have been misclassified due to a lack of clear classification criteria. Since this is a cross-sectional study, the analyses do not provide information about causality, for example for the fact that despite lower median hemoglobin concentrations in older women than in older men, the impact of anemia on HRQoL occurred at the same hemoglobin concentration. Additionally, given the observational nature of the study, it was not possible to exclude the role of unknown or unmeasured confounding variables. A third limitation is that HRQoL was measured with the RAND-36 questionnaire, which is a generic health status questionnaire and not specifically developed to measure QoL in anemic individuals. Finally, it is possible that the results were influenced by volunteer bias.

This study indicates that anemia is associated with decreased survival and HRQoL, especially that concerning physical health, in individuals older than 60 years. After adjusting for confounding variables the impact of anemia was particularly present in individuals with ACI. These results suggest that older individuals might benefit from treatment to increase their hemoglobin values. Furthermore, this study challenges the sex-dependent definition of anemia in individuals older than 60 years, and suggests that in both men and women older than 60 years, the definition currently used in men \[hemoglobin concentration \<13.0 g/dL (8.0 mmol/L)\] could be applied in perspective of HRQoL.
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